Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 14, 1997

View Archived Issues

Shire: FY97 highlights

MycoTox awarded four SBIR awards for antifungal drug discovery

Alkermes issued two U.S. patents for drug delivery system

Extensive preclinical and clinical data on moxifloxacin presented at ICAAC

New results reported for Glaxo Wellcome's anti-HCMV agent at ICAAC

HMR-3004: a new ketolide from Hoechst Marion Roussel

PNU-140690: a novel HIV protease inhibitor in clinical testing at P&U

Sanfetrinem profiled at ICAAC

Heterocyclic compounds from Zeneca for hypercholesterolemia

Pharmacia & Upjohn discloses new distamycin derivatives

New antithrombotics/anticoagulants synthesized at Zeneca

Nonthiazolidinediones for diabetes and obesity described by Merck & Co.

S-4661 efficacy demonstrated in RTI, UTI

Clinical safety and pharmacokinetics of SB-209763 in pediatric patients

Pierre Fabre discloses potent and selective 5-HT1B receptor antagonists

New antimalarial combination launched this week in second market

Yoshitomi-Green Cross merger update

Meeting of Biological Response Modifiers Advisory Committee this week

Cardiovascular/Renal Drugs Advisory Committee meets this month

St. Jude researchers discover new role for p53

Merrem I.V.: a safe and effective option for bacterial meningitis

Schering-Plough extends collaboration with Pharmacopeia to include hepatitis

Verigen licenses Italian rights to anti-TNF-alpha product

Role for NGF in Alzheimer's disease?

Basic tissue regeneration patent issued to The Burnham Institute

Genome Therapeutics reaches milestone in alliance with Schering-Plough

MorphoGen receives notice of allowance for U.S. patent covering PPMSCs

LXR files IDE with FDA for heart preservation solution

Amarillo Biosciences licenses cytokines from Hayashibara

Cubist and Novalon extend collaboration